FDA Approves Expanded Indication for Tenofovir Alafenamide as Hepatitis B Treatment
The new indication includes pediatric patients aged 6 years and older who weigh at least 25 kg and have compensated liver disease.
Source: pharmacytimes.com
📰 Krek School News
Krek School News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Krek School. Real-time updates on events, politics, business and more.